B · Normal
[The concept of innovative drugs fluctuated and fell, and Alex dropped by 20cm.] On October 8, the concept of innovative drugs fluctuated and fell by 20cm, with Ellis falling by the limit of 20cm, Bepsis falling by more than 10%, and Yahong Pharmaceutical, Maiwei Biotech, Technomax, Huiyu Pharmaceutical, Rejing Biotech, etc. followed suit. On the news, Arris announced that the phase III clinical trial of fumetinib did not meet the primary study endpoint. Affected by this news, partner ArriVent's US stock price plummeted 47% in a single day on October 6.
Live broadcast 🕐 2026-10-08 09:41
#clinical trial #Live broadcast #Innovative drugs #hot landscape creature
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Mengke Pharmaceutical: Signed an exclusive license agreement and platform coope 10-09 19:02 On October 9, the onshore RMB closed at 6.6921 against the US dollar, an increas 10-09 16:30 [Analysis of stocks on consecutive boards on October 9: The promotion rate of st 10-09 15:44 [Today’s investment public opinion hot spots] 1) Solid-state batteries: Seven de 10-09 15:36 [October 9th Daily Limit Analysis] On October 9th, a total of 69 stocks in the m 10-09 15:12 [Review: The three major indexes bottomed out and rebounded and collectively clo 10-09 15:02

Comments

0/500
Captcha (click to refresh)
No comments yet